Increased expression of IL-22 and its receptor IL-22R1 and increased activation of STAT3 in human lung cancer cell lines mediate resistance to standard chemotherapy (118), which could be linked to the role of IL-22 in induction of stemness properties. Here, IL22 is linked to lung carcinoma.